4.Guidelines for the early evaluation and management of chronic kidney disease in China.
Chinese Journal of Internal Medicine 2023;62(8):902-930
Chronic kidney disease (CKD) has become a serious public health concern that endangers human health on a global scale. In China, the prevalence of CKD in adults is 10.8%; however, public awareness and the diagnostic rates of CKD in the Chinese population are relatively low. Moreover, China has not yet established a national CKD screening system or developed standardized diagnostic protocols and treatment pathways. Therefore, there is an urgent need to strengthen the prevention and control of CKD and promote the management of this disease. These guidelines were initiated by the Chinese Preventive Medicine Association for Kidney Disease. The quality of evidence and guideline recommendation were determined by applying the Oxford Centre for Evidence-Based Medicine (CEBM) System. These new guidelines describe 38 recommendations that aim to standardize the early screening, management, diagnosis and treatment of CKD, thus promoting the integrated prevention and control of kidney disease in China.
Adult
;
Humans
;
Renal Insufficiency, Chronic/therapy*
;
Prevalence
;
China/epidemiology*
6.The current status of diabetic nephropathy in Korea.
Korean Journal of Medicine 2009;77(6):667-669
The number of patients beginning renal replacement therapy (RRT) in Korea has grown exponentially over the past two decades. Patients with end-stage renal disease attributed to diabetes accounted for most of this increase (45% of new patients requiring RRT). The estimated prevalence of diabetic nephropathy in diabetics in Korea is 30% or more. The early detection and effective treatment of nephropathy in diabetics would prevent or delay the progression of chronic kidney disease. Therefore, comprehensive health intervention to control the increasing prevalence of diabetes and promote early awareness and aggressive management of diabetic nephropathy are needed.
Diabetes Mellitus
;
Diabetic Nephropathies
;
Humans
;
Kidney Failure, Chronic
;
Korea
;
Prevalence
;
Renal Insufficiency, Chronic
;
Renal Replacement Therapy
7.Dyslipidemia promotes the progression of chronic kidney disease.
Chinese Medical Journal 2013;126(7):1203-1206
8.Management of hypertension in non-dialysis and dialysis patients with chronic kidney disease: Chinese expert consensus.
Chinese Journal of Internal Medicine 2023;62(7):748-774
Chronic kidney disease (CKD) is a global public health problem that is usually progressive. Hypertension is a risk factor for the progression of CKD, and cardiovascular disease is the most common cause of death in patients with CKD. In Chinese patients with CKD, there is a high prevalence of hypertension and a poor rate of control. Several studies have demonstrated that effective blood pressure control can delay the progression of kidney disease and reduce the risk of cardiovascular events and all-cause mortality. Based on previously published high-quality evidence, guidelines and consensus reports, the Zhongguancun Nephropathy and Blood Purification Innovation Alliance formulated a new consensus. This consensus includes blood pressure measurement; the blood pressure management of non-dialysis patients, dialysis patients and kidney transplantation patients, and the interaction between commonly used drugs and antihypertensive drugs. The consensus aims to further strengthen the standardization and safety of blood pressure management in CKD patients, delay disease progression, reduce disease burden, and comprehensively improve the quality-of-life and prognosis of patients with CKD.
Humans
;
Cardiovascular Diseases
;
Consensus
;
East Asian People
;
Hypertension/therapy*
;
Renal Insufficiency, Chronic/therapy*
;
Renal Dialysis
10.New dialysis treatment options for patients with end-stage chronic kidney disease.
Korean Journal of Medicine 2009;76(5):528-537
Since the first hemodialysis and peritoneal dialysis were performed in humans in the early 1900s, the survival rates of patients with end-stage renal disease have increased. The number of patients in need of renal replacement therapy (RRT) is increasing, and there have been substantial advances in RRT modalities and technologies. To improve the patient outcomes requiring RRT, progress has been made to improve the efficiency and biocompatibility of dialysis in both hemodialysis and peritoneal dialysis. This review covers the basic principles of dialysis and the history of technological advances in hemodialysis and peritoneal dialysis. In addition, it includes the benefits of hemodiafiltration, new peritoneal dialysis solutions and automated peritoneal dialysis.
Dialysis
;
Hemodiafiltration
;
Humans
;
Kidney Failure, Chronic
;
Peritoneal Dialysis
;
Renal Dialysis
;
Renal Insufficiency, Chronic
;
Renal Replacement Therapy
;
Survival Rate